HALEON PLC (H6D0.DE) Fundamental Analysis & Valuation

FRA:H6D0 • GB00BMX86B70

4.383 EUR
-0.02 (-0.39%)
Last: Mar 9, 2026, 07:00 PM

This H6D0.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to H6D0. H6D0 was compared to 54 industry peers in the Pharmaceuticals industry. There are concerns on the financial health of H6D0 while its profitability can be described as average. H6D0 has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

5

1. H6D0.DE Profitability Analysis

1.1 Basic Checks

  • In the past year H6D0 was profitable.
  • In the past year H6D0 had a positive cash flow from operations.
  • In the past 5 years H6D0 has always been profitable.
  • Each year in the past 5 years H6D0 had a positive operating cash flow.
H6D0.DE Yearly Net Income VS EBIT VS OCF VS FCFH6D0.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 5.11%, H6D0 is in line with its industry, outperforming 46.30% of the companies in the same industry.
  • With a Return On Equity value of 10.15%, H6D0 perfoms like the industry average, outperforming 46.30% of the companies in the same industry.
  • The Return On Invested Capital of H6D0 (6.91%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA 5.11%
ROE 10.15%
ROIC 6.91%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
H6D0.DE Yearly ROA, ROE, ROICH6D0.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 2 4 6 8

1.3 Margins

  • H6D0 has a better Profit Margin (15.11%) than 61.11% of its industry peers.
  • H6D0's Profit Margin has improved in the last couple of years.
  • H6D0's Operating Margin of 22.36% is in line compared to the rest of the industry. H6D0 outperforms 53.70% of its industry peers.
  • In the last couple of years the Operating Margin of H6D0 has remained more or less at the same level.
  • Looking at the Gross Margin, with a value of 64.69%, H6D0 is doing worse than 62.96% of the companies in the same industry.
  • In the last couple of years the Gross Margin of H6D0 has remained more or less at the same level.
Industry RankSector Rank
OM 22.36%
PM (TTM) 15.11%
GM 64.69%
OM growth 3Y-0.1%
OM growth 5Y0.08%
PM growth 3Y15.68%
PM growth 5Y5.48%
GM growth 3Y1.46%
GM growth 5Y0.97%
H6D0.DE Yearly Profit, Operating, Gross MarginsH6D0.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 20 40 60

3

2. H6D0.DE Health Analysis

2.1 Basic Checks

  • H6D0 has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • H6D0 has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
H6D0.DE Yearly Shares OutstandingH6D0.DE Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B
H6D0.DE Yearly Total Debt VS Total AssetsH6D0.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

  • H6D0 has an Altman-Z score of 1.90. This is not the best score and indicates that H6D0 is in the grey zone with still only limited risk for bankruptcy at the moment.
  • H6D0 has a Altman-Z score of 1.90. This is in the lower half of the industry: H6D0 underperforms 62.96% of its industry peers.
  • H6D0 has a debt to FCF ratio of 3.88. This is a good value and a sign of high solvency as H6D0 would need 3.88 years to pay back of all of its debts.
  • H6D0's Debt to FCF ratio of 3.88 is in line compared to the rest of the industry. H6D0 outperforms 59.26% of its industry peers.
  • A Debt/Equity ratio of 0.47 indicates that H6D0 is not too dependend on debt financing.
  • The Debt to Equity ratio of H6D0 (0.47) is better than 61.11% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 3.88
Altman-Z 1.9
ROIC/WACC0.75
WACC9.2%
H6D0.DE Yearly LT Debt VS Equity VS FCFH6D0.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

2.3 Liquidity

  • A Current Ratio of 0.92 indicates that H6D0 may have some problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 0.92, H6D0 is doing worse than 83.33% of the companies in the same industry.
  • H6D0 has a Quick Ratio of 0.92. This is a bad value and indicates that H6D0 is not financially healthy enough and could expect problems in meeting its short term obligations.
  • H6D0 has a worse Quick ratio (0.71) than 79.63% of its industry peers.
Industry RankSector Rank
Current Ratio 0.92
Quick Ratio 0.71
H6D0.DE Yearly Current Assets VS Current LiabilitesH6D0.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

3

3. H6D0.DE Growth Analysis

3.1 Past

  • H6D0 shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.59%.
  • H6D0 shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 17.56% yearly.
  • The Revenue has decreased by -0.61% in the past year.
  • Measured over the past years, H6D0 shows a small growth in Revenue. The Revenue has been growing by 5.78% on average per year.
EPS 1Y (TTM)6.59%
EPS 3Y1.58%
EPS 5Y17.56%
EPS Q2Q%281.35%
Revenue 1Y (TTM)-0.61%
Revenue growth 3Y5.58%
Revenue growth 5Y5.78%
Sales Q2Q%-0.29%

3.2 Future

  • Based on estimates for the next years, H6D0 will show a small growth in Earnings Per Share. The EPS will grow by 7.38% on average per year.
  • H6D0 is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.26% yearly.
EPS Next Y6.33%
EPS Next 2Y8.54%
EPS Next 3Y8.95%
EPS Next 5Y7.38%
Revenue Next Year-1.37%
Revenue Next 2Y1.08%
Revenue Next 3Y2.23%
Revenue Next 5Y3.26%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
H6D0.DE Yearly Revenue VS EstimatesH6D0.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 5B 10B 15B
H6D0.DE Yearly EPS VS EstimatesH6D0.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.05 0.1 0.15 0.2 0.25

4

4. H6D0.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • H6D0 is valuated rather expensively with a Price/Earnings ratio of 20.87.
  • The rest of the industry has a similar Price/Earnings ratio as H6D0.
  • H6D0 is valuated rather cheaply when we compare the Price/Earnings ratio to 26.46, which is the current average of the S&P500 Index.
  • H6D0 is valuated rather expensively with a Price/Forward Earnings ratio of 18.02.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of H6D0 is on the same level as its industry peers.
  • H6D0 is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 24.65, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 20.87
Fwd PE 18.02
H6D0.DE Price Earnings VS Forward Price EarningsH6D0.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, H6D0 is valued a bit cheaper than 77.78% of the companies in the same industry.
  • 98.15% of the companies in the same industry are more expensive than H6D0, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 7.62
EV/EBITDA 8.59
H6D0.DE Per share dataH6D0.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates H6D0 does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)3.3
PEG (5Y)1.19
EPS Next 2Y8.54%
EPS Next 3Y8.95%

3

5. H6D0.DE Dividend Analysis

5.1 Amount

  • H6D0 has a Yearly Dividend Yield of 1.86%. Purely for dividend investing, there may be better candidates out there.
  • H6D0's Dividend Yield is comparable with the industry average which is at 1.91.
  • H6D0's Dividend Yield is comparable with the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 1.86%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
H6D0.DE Yearly Dividends per shareH6D0.DE Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 2026 0.02 0.04 0.06

5.3 Sustainability

  • H6D0 pays out 36.71% of its income as dividend. This is a sustainable payout ratio.
DP36.71%
EPS Next 2Y8.54%
EPS Next 3Y8.95%
H6D0.DE Yearly Income VS Free CF VS DividendH6D0.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B
H6D0.DE Dividend Payout.H6D0.DE Dividend Payout, showing the Payout Ratio.H6D0.DE Dividend Payout.PayoutRetained Earnings

H6D0.DE Fundamentals: All Metrics, Ratios and Statistics

HALEON PLC

FRA:H6D0 (3/9/2026, 7:00:00 PM)

4.383

-0.02 (-0.39%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-25
Earnings (Next)04-29
Inst Owners60.22%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap19.52B
Revenue(TTM)11.23B
Net Income(TTM)1.67B
Analysts80
Price Target5.09 (16.13%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.86%
Yearly Dividend0.07
Dividend Growth(5Y)N/A
DP36.71%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.73%
Min Revenue beat(2)-3.78%
Max Revenue beat(2)-1.69%
Revenue beat(4)0
Avg Revenue beat(4)-3.44%
Min Revenue beat(4)-4.82%
Max Revenue beat(4)-1.69%
Revenue beat(8)0
Avg Revenue beat(8)-3.28%
Revenue beat(12)1
Avg Revenue beat(12)-2.85%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.51%
PT rev (3m)3.31%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)1.45%
EPS NY rev (3m)1.01%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.08%
Revenue NY rev (3m)-1.08%
Valuation
Industry RankSector Rank
PE 20.87
Fwd PE 18.02
P/S 1.53
P/FCF 7.62
P/OCF 6.42
P/B 1.03
P/tB N/A
EV/EBITDA 8.59
EPS(TTM)0.21
EY4.79%
EPS(NY)0.24
Fwd EY5.55%
FCF(TTM)0.58
FCFY13.13%
OCF(TTM)0.68
OCFY15.57%
SpS2.86
BVpS4.25
TBVpS-2.38
PEG (NY)3.3
PEG (5Y)1.19
Graham Number4.48
Profitability
Industry RankSector Rank
ROA 5.11%
ROE 10.15%
ROCE 8.9%
ROIC 6.91%
ROICexc 7.26%
ROICexgc 251.94%
OM 22.36%
PM (TTM) 15.11%
GM 64.69%
FCFM 20.14%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-0.1%
OM growth 5Y0.08%
PM growth 3Y15.68%
PM growth 5Y5.48%
GM growth 3Y1.46%
GM growth 5Y0.97%
F-Score8
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 3.88
Debt/EBITDA 2.75
Cap/Depr 114.72%
Cap/Sales 3.74%
Interest Coverage 6.91
Cash Conversion 93.21%
Profit Quality 133.23%
Current Ratio 0.92
Quick Ratio 0.71
Altman-Z 1.9
F-Score8
WACC9.2%
ROIC/WACC0.75
Cap/Depr(3y)107.2%
Cap/Depr(5y)109.42%
Cap/Sales(3y)3.18%
Cap/Sales(5y)3.14%
Profit Quality(3y)146.3%
Profit Quality(5y)135.74%
High Growth Momentum
Growth
EPS 1Y (TTM)6.59%
EPS 3Y1.58%
EPS 5Y17.56%
EPS Q2Q%281.35%
EPS Next Y6.33%
EPS Next 2Y8.54%
EPS Next 3Y8.95%
EPS Next 5Y7.38%
Revenue 1Y (TTM)-0.61%
Revenue growth 3Y5.58%
Revenue growth 5Y5.78%
Sales Q2Q%-0.29%
Revenue Next Year-1.37%
Revenue Next 2Y1.08%
Revenue Next 3Y2.23%
Revenue Next 5Y3.26%
EBIT growth 1Y-3.1%
EBIT growth 3Y0.42%
EBIT growth 5Y2.28%
EBIT Next Year20.78%
EBIT Next 3Y10.91%
EBIT Next 5Y9.2%
FCF growth 1Y12%
FCF growth 3Y8.58%
FCF growth 5Y15.32%
OCF growth 1Y14.47%
OCF growth 3Y8.49%
OCF growth 5Y13.36%

HALEON PLC / H6D0.DE FAQ

Can you provide the ChartMill fundamental rating for HALEON PLC?

ChartMill assigns a fundamental rating of 4 / 10 to H6D0.DE.


Can you provide the valuation status for HALEON PLC?

ChartMill assigns a valuation rating of 4 / 10 to HALEON PLC (H6D0.DE). This can be considered as Fairly Valued.


How profitable is HALEON PLC (H6D0.DE) stock?

HALEON PLC (H6D0.DE) has a profitability rating of 5 / 10.


Can you provide the financial health for H6D0 stock?

The financial health rating of HALEON PLC (H6D0.DE) is 3 / 10.


How sustainable is the dividend of HALEON PLC (H6D0.DE) stock?

The dividend rating of HALEON PLC (H6D0.DE) is 3 / 10 and the dividend payout ratio is 36.71%.